CN101238891A - 一种强身、健身保健饮料 - Google Patents
一种强身、健身保健饮料 Download PDFInfo
- Publication number
- CN101238891A CN101238891A CNA2008100581841A CN200810058184A CN101238891A CN 101238891 A CN101238891 A CN 101238891A CN A2008100581841 A CNA2008100581841 A CN A2008100581841A CN 200810058184 A CN200810058184 A CN 200810058184A CN 101238891 A CN101238891 A CN 101238891A
- Authority
- CN
- China
- Prior art keywords
- parts
- health
- beverage
- portions
- tangerine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036541 health Effects 0.000 title claims abstract description 26
- 235000013361 beverage Nutrition 0.000 title claims abstract description 21
- 235000012907 honey Nutrition 0.000 claims abstract description 14
- 241000675108 Citrus tangerina Species 0.000 claims description 30
- 244000241838 Lycium barbarum Species 0.000 claims description 27
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 27
- 241001092040 Crataegus Species 0.000 claims description 21
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 21
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 21
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 21
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 21
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 21
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 21
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 21
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 21
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 21
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 21
- 229930006000 Sucrose Natural products 0.000 claims description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 16
- 239000005720 sucrose Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 235000013681 dietary sucrose Nutrition 0.000 claims description 4
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 239000000796 flavoring agent Substances 0.000 abstract description 12
- 235000019634 flavors Nutrition 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 230000035622 drinking Effects 0.000 abstract description 6
- 230000002929 anti-fatigue Effects 0.000 abstract description 4
- 235000017784 Mespilus germanica Nutrition 0.000 abstract description 3
- 235000000560 Mimusops elengi Nutrition 0.000 abstract description 3
- 235000007837 Vangueria infausta Nutrition 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 2
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 2
- 239000011575 calcium Substances 0.000 abstract description 2
- 230000036737 immune function Effects 0.000 abstract description 2
- 235000000346 sugar Nutrition 0.000 abstract description 2
- 240000002624 Mespilus germanica Species 0.000 abstract 2
- MCTQNEBFZMBRSQ-GEEYTBSJSA-N Chrysoidine Chemical compound Cl.NC1=CC(N)=CC=C1\N=N\C1=CC=CC=C1 MCTQNEBFZMBRSQ-GEEYTBSJSA-N 0.000 abstract 1
- 230000003471 anti-radiation Effects 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 238000000034 method Methods 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 229940096919 glycogen Drugs 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000029087 digestion Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 241000756943 Codonopsis Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000008083 Urea Assay Methods 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 枸杞原料重量(克) | 橘红原料重量(克) | 山楂原料重量(克) | 蜂蜜重量(克) | 蔗糖重量(克) |
空白对照0 | 0 | 0 | 0 | 0 | 0 |
复方1 | 400 | 0 | 0 | 50 | 200 |
复方2 | 200 | 0 | 200 | 50 | 200 |
复方3 | 80 | 200 | 120 | 50 | 200 |
复方4 | 200 | 100 | 100 | 50 | 200 |
组别 | 动物数(只) | 实验前体重(克) | 实验后体重(克) | 游泳时间(秒) |
0 | 15 | 19.4±1.4 | 27.3±0.7 | 147.2±57.4 |
1 | 15 | 19.6±1.6 | 27.7±0.4 | 178.9±130.1 |
2 | 15 | 19.3±1.3 | 27.6±0.5 | 201.7±141.1 |
3 | 15 | 19.5±1.5 | 27.2±0.8 | 211.3±138.5 |
4 | 15 | 19.5±1.3 | 27.8±0.3 | 286.6±153.8 |
组别 | 动物数(只) | 实验前体重(克) | 实验后体重(克) | 血乳酸曲线下面积 |
0 | 15 | 19.7±0.5 | 26.6±0.8 | 98±19 |
1 | 15 | 19.3±0.7 | 26.7±0.6 | 89±16 |
2 | 15 | 19.6±0.5 | 26.8±0.7 | 86±17 |
3 | 15 | 19.4±0.8 | 26.8±0.8 | 84±16 |
4 | 15 | 19.7±0.4 | 27.3±0.9 | 82±11 |
组别 | 动物数(只) | 实验前体重(克) | 实验后体重(克) | 肝糖元(mg/g肝组织) |
0 | 15 | 18.7±1.5 | 26.3±0.5 | 2.128±0.449 |
1 | 15 | 18.3±1.7 | 26.7±0.3 | 2.463±0.648 |
2 | 15 | 18.6±1.3 | 26.6±0.3 | 2.981±0.713 |
3 | 15 | 18.5±1.6 | 26.9±0.7 | 3.527±0.691 |
4 | 15 | 18.6±1.3 | 27.1±0.6 | 4.241±0.733 |
组别 | 动物数(只) | 实验前体重(克) | 实验后体重(克) | 血清尿素(mmol/L) |
0 | 15 | 20.7±0.6 | 26.6±0.6 | 11.28±0.89 |
1 | 15 | 19.9±0.7 | 26.9±0.7 | 10.42±1.12 |
2 | 15 | 20.1±0.4 | 27.1±0.7 | 9.95±1.07 |
3 | 15 | 19.4±0.6 | 27.5±0.4 | 9.48±1.43 |
4 | 15 | 19.8±0.5 | 27.4±0.8 | 9.46±1.18 |
枸杞原料重量(克) | 橘红原料重量(克) | 山楂原料重量(克) |
200 | 100 | 100 |
试样号 | 1 | 2 | 3 | 4 | 5 |
总分 | 7 | 9 | 8 | 6 | 6 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100581841A CN101238891B (zh) | 2008-03-17 | 2008-03-17 | 一种强身、健身保健饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100581841A CN101238891B (zh) | 2008-03-17 | 2008-03-17 | 一种强身、健身保健饮料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101238891A true CN101238891A (zh) | 2008-08-13 |
CN101238891B CN101238891B (zh) | 2010-12-22 |
Family
ID=39930937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100581841A Active CN101238891B (zh) | 2008-03-17 | 2008-03-17 | 一种强身、健身保健饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101238891B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101348761B (zh) * | 2008-08-20 | 2011-10-26 | 杨柳青 | 一种保健酒 |
CN107854565A (zh) * | 2016-09-22 | 2018-03-30 | 北京中医药大学 | 一种抗辐射的中药组合物 |
CN108402238A (zh) * | 2018-03-20 | 2018-08-17 | 重庆旭焰实业有限公司 | 一种蜂蜜柚子茶及其制备方法和应用 |
CN109717434A (zh) * | 2019-01-30 | 2019-05-07 | 宁夏碧蜂源蜂产业有限公司 | 适宜老年人食用的保健蜂蜜酱及制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1124628A (zh) * | 1993-11-18 | 1996-06-19 | 唐桂安 | 解酒饮料 |
CN1201619A (zh) * | 1997-06-05 | 1998-12-16 | 韩志平 | 一种枸杞山楂饮料 |
CN1785024A (zh) * | 2005-05-10 | 2006-06-14 | 刘建伟 | 咽炎护嗓袋泡茶 |
-
2008
- 2008-03-17 CN CN2008100581841A patent/CN101238891B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101348761B (zh) * | 2008-08-20 | 2011-10-26 | 杨柳青 | 一种保健酒 |
CN107854565A (zh) * | 2016-09-22 | 2018-03-30 | 北京中医药大学 | 一种抗辐射的中药组合物 |
CN108402238A (zh) * | 2018-03-20 | 2018-08-17 | 重庆旭焰实业有限公司 | 一种蜂蜜柚子茶及其制备方法和应用 |
CN109717434A (zh) * | 2019-01-30 | 2019-05-07 | 宁夏碧蜂源蜂产业有限公司 | 适宜老年人食用的保健蜂蜜酱及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101238891B (zh) | 2010-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104643225A (zh) | 一种改善胃肠功能、提高免疫力的甘草植物饮料及其制备方法 | |
CN101904504A (zh) | 五行酵素液及其制备方法 | |
CN104041903A (zh) | 一种富硒青钱柳饮品及其制备方法 | |
CN103734751A (zh) | 一种复合膳食纤维及其制法 | |
CN105112265A (zh) | 一种保健无花果酒及其制作方法 | |
CN102987477B (zh) | 一种保健饮料 | |
CN105998762A (zh) | 一种含绞股蓝的防三高及痛风的保健药物组合物 | |
CN104757670A (zh) | 一种甘草保健植物饮料及其制备方法 | |
CN107488545A (zh) | 一种新型薏仁米酒及其酿造方法 | |
CN101238891B (zh) | 一种强身、健身保健饮料 | |
CN104840778A (zh) | 中药发酵乌发制剂、制备方法及用途 | |
CN102613487A (zh) | 一种低血糖指数固元粥及其应用于工厂化生产的方法 | |
CN104017715A (zh) | 一种百香果醋及其制作方法 | |
CN102273681A (zh) | 一种抗疲劳运动饮料 | |
CN103355444A (zh) | 一种健脾补气保健茶膏及制备方法 | |
CN103920140B (zh) | 一种人用降糖减肥降脂复方制剂 | |
CN103238757A (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN104905364A (zh) | 一种降血糖的饮料及其制备方法 | |
CN104087465B (zh) | 一种预防高血脂的保健葡萄酒及其制备工艺 | |
CN107737280A (zh) | 用于治疗糖尿病的中药组合物及其制备方法和应用 | |
CN107502509A (zh) | 一种低酒精含量覆盆子保健酒饮料及其制备方法 | |
CN103549600A (zh) | 一种纯天然营养免疫保健饮料的配制方法 | |
CN107441332A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物及制备方法 | |
CN106820031A (zh) | 一种具有保健功能蜜制品及其制备方法 | |
CN103349107B (zh) | 补脾养心保健茶膏及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Yunnan crystal Natural Pharmaceutical Co. Ltd. Assignor: Wei Yuling Contract record no.: 2011530000056 Denomination of invention: Body-building health care beverage Granted publication date: 20101222 License type: Exclusive License Open date: 20080813 Record date: 20110805 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160106 Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee after: Yunnan crystal Natural Pharmaceutical Co. Ltd. Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Wei Yuling |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee after: YUNNAN CRYSTAL NATURAL PHARMACEUTICAL CO., LTD. Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Yunnan crystal Natural Pharmaceutical Co. Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee after: Sailing Pharmaceutical Technology Group Co., Ltd Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Yunnan Kress Pharmaceutical Co.,Ltd. |